Article
Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
2 May 2022
Abstract excerpt
two pivotal categories of enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs). In previous studies, dysregulation of lysine acetylation and deacetylation has been reported to be associated with the genesis and development of malignancy. Scientists have recently explored acetylation/deacetylation patterns and prospective cancer therapy techniques, and the FDA has approved four HDAC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
